SRF Stock Downgraded: China, US Tariffs Hammer Growth, Valuation Strains

CHEMICALS
Whalesbook Logo
AuthorAarav Shah|Published at:
SRF Stock Downgraded: China, US Tariffs Hammer Growth, Valuation Strains
Overview

SRF's Q3FY26 performance was mixed, with a strong chemicals segment offsetting weaker performance films and technical textiles businesses. Cheap Chinese imports and U.S. tariffs are pressuring various product lines. Analysts cite an expensive valuation, leading to a downgrade to Equal Weight, advising investors to wait for improved entry conditions.

Business Segment Headwinds

SRF Limited reported mixed financial results for the third quarter of fiscal year 2026. While its chemicals business, accounting for half of sales, saw a robust 22 percent year-on-year growth driven by firm hydrofluorocarbon (HFC) refrigerant gas prices and improved volumes, other segments faced significant headwinds. The performance films division reported disruptions from GST 2 compliance and sustained competition from cheaper imports in Thailand and Hungary. Similarly, the technical textiles segment grappled with aggressive pricing from Chinese competitors and negative impacts from U.S. tariffs on belting fabrics, signaling broad competitive pressures.

Outlook and Strategic Investments

Despite near-term challenges, management anticipates a sequential improvement in the chemicals business during the fourth quarter. The company is investing in future growth with a ₹282 crore project at its Odisha site for future chemical facilities and a strategic agreement with Chemours to manufacture advanced fluoropolymers and fluoroelastomers, targeting high-growth sectors like semiconductors and aerospace by December 2026. Future capex for FY27 is projected between ₹1,500 crore to ₹2,000 crore, including a ₹180 crore investment for a pharma intermediate plant. The company also plans investments in next-generation refrigeration gases at its Odisha facility to comply with evolving global environmental regulations.

Valuation Concerns and Recommendation

Analysts have trimmed near-term estimates following the Q3 performance, noting that SRF stock trades at a premium valuation of 18.4 times Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization for FY28. While acknowledging the sustained benefits from refrigerant gases and the transient nature of some business concerns, the current valuation is deemed unlucrative. Consequently, the rating has been downgraded from Overweight to Equal Weight, with investors advised to seek better entry levels or await resolution of concerns related to competition from China and trade policies in the USA. SRF's allocation has also been reduced in the Diwali Portfolio.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.